API reference

Acetazolamide

CAS number
59-66-5
Molecular formula
C4H6N4O3S2
Molecular weight
222.3 g/mol
Acetazolamide — 2D structure
2D structure (PubChem)

About this molecule

One of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Source: DrugBank, via PubChem.

Identifiers

IUPAC name
N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide
InChIKey
BZKPWHYZMXOIDC-UHFFFAOYSA-N
SMILES
CC(=O)NC1=NN=C(S1)S(=O)(=O)N
Other CAS numbers recorded
124442-28-0
PubChem CID
1986

Also known as

acetazolamide · Acetamox · Glaupax · Edemox · N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide · Acetazolamid · Nephramide · Defiltran

Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.

Tell us the grade, the quantity and the market.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com